162 related articles for article (PubMed ID: 33356073)
41. Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy.
Kiss S; Ahmed M; Letko E; Foster CS
Ophthalmology; 2005 Jun; 112(6):1066-71. PubMed ID: 15936442
[TBL] [Abstract][Full Text] [Related]
42. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients.
Siepmann K; Huber M; Stübiger N; Deuter C; Zierhut M
Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):788-94. PubMed ID: 16163494
[TBL] [Abstract][Full Text] [Related]
43. Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology.
Broen JCA; van Laar JM
Nat Rev Rheumatol; 2020 Mar; 16(3):167-178. PubMed ID: 32055040
[TBL] [Abstract][Full Text] [Related]
44. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
[TBL] [Abstract][Full Text] [Related]
45. Outcomes of Vogt-Koyanagi-Harada Disease: A Subanalysis From a Randomized Clinical Trial of Antimetabolite Therapies.
Shen E; Rathinam SR; Babu M; Kanakath A; Thundikandy R; Lee SM; Browne EN; Porco TC; Acharya NR
Am J Ophthalmol; 2016 Aug; 168():279-286. PubMed ID: 27296490
[TBL] [Abstract][Full Text] [Related]
46. Mycophenolate mofetil and cyclophosphamide treatments suppress inflammation intensity in an experimental model of autoimmune uveitis.
Klímová A; Seidler Štanogová P; Heissigerová J; Svozílková P; Kučera T
Folia Biol (Praha); 2014; 60(5):228-34. PubMed ID: 25863040
[TBL] [Abstract][Full Text] [Related]
47. Comparison Between Methotrexate and Mycophenolate Mofetil Monotherapy for the Control of Noninfectious Ocular Inflammatory Diseases.
Gangaputra SS; Newcomb CW; Joffe MM; Dreger K; Begum H; Artornsombudh P; Pujari SS; Daniel E; Sen HN; Suhler EB; Thorne JE; Bhatt NP; Foster CS; Jabs DA; Nussenblatt RB; Rosenbaum JT; Levy-Clarke GA; Kempen JH;
Am J Ophthalmol; 2019 Dec; 208():68-75. PubMed ID: 31344346
[TBL] [Abstract][Full Text] [Related]
48. Mycophenolate mofetil for Crohn's disease: short-term efficacy and long-term outcome.
Wenzl HH; Hinterleitner TA; Aichbichler BW; Fickert P; Petritsch W
Aliment Pharmacol Ther; 2004 Feb; 19(4):427-34. PubMed ID: 14871282
[TBL] [Abstract][Full Text] [Related]
49. Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients.
Kovarik JM; Pescovitz MD; Sollinger HW; Kaplan B; Legendre C; Salmela K; Book BK; Gerbeau C; Girault D; Somberg K;
Clin Transplant; 2001 Apr; 15(2):123-30. PubMed ID: 11264639
[TBL] [Abstract][Full Text] [Related]
50. [Immunosuppressive therapy with mycophenolate mofetil (CellCept) in treatment of uveitis].
Zierhut M; Stübiger N; Aboalchamat W; Landenberger H; Bialasiewicz AA; Engelmann K
Ophthalmologe; 2001 Jul; 98(7):647-51. PubMed ID: 11490743
[TBL] [Abstract][Full Text] [Related]
51. Long-Term Treatment With Azathioprine and Mycophenolate Mofetil for Myositis-Related Interstitial Lung Disease.
Huapaya JA; Silhan L; Pinal-Fernandez I; Casal-Dominguez M; Johnson C; Albayda J; Paik JJ; Sanyal A; Mammen AL; Christopher-Stine L; Danoff SK
Chest; 2019 Nov; 156(5):896-906. PubMed ID: 31238042
[TBL] [Abstract][Full Text] [Related]
52. Comparative efficacy of steroid-sparing therapies for non-infectious uveitis.
Knickelbein JE; Kim M; Argon E; Nussenblatt RB; Sen NH
Expert Rev Ophthalmol; 2017; 12(4):313-319. PubMed ID: 30867672
[TBL] [Abstract][Full Text] [Related]
53. Mycophenolate mofetil therapy in uveitis: analysis of eight cases in a tertiary ophthalmic care centre in India.
Rathore VM; Agrawal R; Chaudhary SP; Biswas J
Int Ophthalmol; 2009 Apr; 29(2):117-22. PubMed ID: 18080093
[TBL] [Abstract][Full Text] [Related]
54. Reduced human IgG anti-ATGAM antibody formation in renal transplant recipients receiving mycophenolate mofetil.
Kimball JA; Pescovitz MD; Book BK; Norman DJ
Transplantation; 1995 Dec; 60(12):1379-83. PubMed ID: 8545860
[TBL] [Abstract][Full Text] [Related]
55. Mycophenolate sodium for the treatment of chronic non-infectious uveitis of childhood.
Doycheva D; Zierhut M; Blumenstock G; Sobolewska B; Voykov B; Hohmann J; Spitzer MS; Deuter C
Br J Ophthalmol; 2016 Aug; 100(8):1071-5. PubMed ID: 26567021
[TBL] [Abstract][Full Text] [Related]
56. Mycophenolate mofetil: a pharmacoeconomic review of its use in solid organ transplantation.
Young M; Plosker GL
Pharmacoeconomics; 2002; 20(10):675-713. PubMed ID: 12162756
[TBL] [Abstract][Full Text] [Related]
57. Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease.
Oldham JM; Lee C; Valenzi E; Witt LJ; Adegunsoye A; Hsu S; Chen L; Montner S; Chung JH; Noth I; Vij R; Strek ME
Respir Med; 2016 Dec; 121():117-122. PubMed ID: 27888985
[TBL] [Abstract][Full Text] [Related]
58. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Chande N; Townsend CM; Parker CE; MacDonald JK
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD000545. PubMed ID: 27783843
[TBL] [Abstract][Full Text] [Related]
59. The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes.
Baven-Pronk AM; Coenraad MJ; van Buuren HR; de Man RA; van Erpecum KJ; Lamers MM; Drenth JP; van den Berg AP; Beuers UH; den Ouden J; Koek GH; van Nieuwkerk CM; Bouma G; Brouwer JT; van Hoek B
Aliment Pharmacol Ther; 2011 Aug; 34(3):335-43. PubMed ID: 21668459
[TBL] [Abstract][Full Text] [Related]
60. The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients.
Ensley RD; Bristow MR; Olsen SL; Taylor DO; Hammond EH; O'Connell JB; Dunn D; Osburn L; Jones KW; Kauffman RS
Transplantation; 1993 Jul; 56(1):75-82. PubMed ID: 8333071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
